BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18021217)

  • 1. Mammaglobin B expression in human endometrial cancer.
    Tassi RA; Bignotti E; Falchetti M; Calza S; Ravaggi A; Rossi E; Martinelli F; Bandiera E; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2008; 18(5):1090-6. PubMed ID: 18021217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
    Zafrakas M; Petschke B; Donner A; Fritzsche F; Kristiansen G; Knüchel R; Dahl E
    BMC Cancer; 2006 Apr; 6():88. PubMed ID: 16603086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
    Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
    Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.
    Tassi RA; Calza S; Ravaggi A; Bignotti E; Odicino FE; Tognon G; Donzelli C; Falchetti M; Rossi E; Todeschini P; Romani C; Bandiera E; Zanotti L; Pecorelli S; Santin AD
    BMC Cancer; 2009 Jul; 9():253. PubMed ID: 19635143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DJ-1 in endometrial cancer: a possible biomarker to improve differential diagnosis between subtypes.
    Morelli M; Scumaci D; Di Cello A; Venturella R; Donato G; Faniello MC; Quaresima B; Cuda G; Zullo F; Costanzo F
    Int J Gynecol Cancer; 2014 May; 24(4):649-58. PubMed ID: 24614826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
    Onuma K; Dabbs DJ; Bhargava R
    Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilin B: A gene preferentially expressed in breast tissue and upregulated in breast cancer.
    Culleton J; O'Brien N; Ryan BM; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Int J Cancer; 2007 Mar; 120(5):1087-92. PubMed ID: 17163411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers.
    Aihara T; Fujiwara Y; Miyake Y; Okami J; Okada Y; Iwao K; Sugita Y; Tomita N; Sakon M; Shiozaki H; Monden M
    Cancer Lett; 2000 Mar; 150(1):79-84. PubMed ID: 10755390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered expression of fibroblast growth factor receptor 2 isoform IIIc: relevance to endometrioid adenocarcinoma carcinogenesis and histological differentiation.
    Peng WX; Kudo M; Fujii T; Teduka K; Naito Z
    Int J Clin Exp Pathol; 2014; 7(3):1069-76. PubMed ID: 24696723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of osteopontin expression in endometrioid endometrial cancer and ovarian endometrioid cancer.
    Hashiguchi Y; Tsuda H; Bandera CA; Nishimura S; Inoue T; Kawamura N; Berkowitz RS; Mok SC
    Med Oncol; 2006; 23(2):205-12. PubMed ID: 16720920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation.
    Sjödin A; Ljuslinder I; Henriksson R; Hedman H
    Anticancer Res; 2008; 28(3A):1493-8. PubMed ID: 18630503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas.
    Bignotti E; Ravaggi A; Tassi RA; Calza S; Rossi E; Falchetti M; Romani C; Bandiera E; Odicino FE; Pecorelli S; Santin AD
    Br J Cancer; 2008 Sep; 99(5):768-73. PubMed ID: 18682706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas.
    Sjödin A; Guo D; Lund-Johansen M; Krossnes BK; Lilleng P; Henriksson R; Hedman H
    Acta Neuropathol; 2005 Apr; 109(4):381-6. PubMed ID: 15668787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody.
    Bignotti E; Ravaggi A; Romani C; Falchetti M; Lonardi S; Facchetti F; Pecorelli S; Varughese J; Cocco E; Bellone S; Schwartz PE; Rutherford TJ; Santin AD
    Int J Gynecol Cancer; 2011 Dec; 21(9):1613-21. PubMed ID: 21892093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulated secretoglobin expression in human lung cancers.
    Sjödin A; Guo D; Sørhaug S; Bjermer L; Henriksson R; Hedman H
    Lung Cancer; 2003 Jul; 41(1):49-56. PubMed ID: 12826312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
    Wu D; Huang HJ; He CN; Wang KY
    Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction.
    Aihara T; Fujiwara Y; Ooka M; Sakita I; Tamaki Y; Monden M
    Breast Cancer Res Treat; 1999 Nov; 58(2):137-40. PubMed ID: 10674878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint expression, microsatellite instability, and mutational burden: Identifying immune biomarker phenotypes in uterine cancer.
    Jones NL; Xiu J; Rocconi RP; Herzog TJ; Winer IS
    Gynecol Oncol; 2020 Feb; 156(2):393-399. PubMed ID: 31882243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
    Alvarez T; Miller E; Duska L; Oliva E
    Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.
    Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S
    Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.